NewLink Genetics Corporation - Product Pipeline Review - 2012

Global Markets Direct, May 2012, Pages: 47

NewLink Genetics Corporation – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “NewLink Genetics Corporation - Product Pipeline Review - 2012” provides data on the NewLink Genetics Corporation’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, NewLink Genetics Corporation’s corporate website, SEC filings, investor presentations and featured press releases, both from NewLink Genetics Corporation and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- NewLink Genetics Corporation - Brief NewLink Genetics Corporation overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of NewLink Genetics Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of NewLink Genetics Corporation with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the NewLink Genetics Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate NewLink Genetics Corporation’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of NewLink Genetics Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the NewLink Genetics Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with NewLink Genetics Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of NewLink Genetics Corporation and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of NewLink Genetics Corporation; NewLink Genetics Corporation - Key Therapeutics; NewLink Genetics Corporation - Pipeline Overview and Promising Molecules; NewLink Genetics Corporation - News; NewLink Genetics Corporation - Latest Updates; NewLink Genetics Corporation - Pipeline; NewLink Genetics Corporation - Discontinued/Dormant Projects

List of Tables
List of Figures
NewLink Genetics Corporation Snapshot
NewLink Genetics Corporation Overview
Key Information
Key Facts
Paladin Labs Inc. – Research and Development Overview
Key Therapeutic Areas
Paladin Labs Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Pipeline Products – Combination Treatment Modalities
Paladin Labs Inc. – Pipeline Products Glance
Paladin Labs Inc. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Paladin Labs Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Paladin Labs Inc. – Drug Profiles
D-1MT
Product Description
Mechanism of Action
R&D Progress
D-1MT + Ad-p53
Product Description
Mechanism of Action
R&D Progress
D-1MT + Taxotere
Product Description
Mechanism of Action
R&D Progress
HyperAcute Lung Cancer Vaccine
Product Description
Mechanism of Action
R&D Progress
HyperAcute-Melanoma Vaccine
Product Description
Mechanism of Action
R&D Progress
HyperAcute-Pancreas Immunotherapy
Product Description
Mechanism of Action
R&D Progress
Paladin Labs Inc. – Pipeline Analysis
Paladin Labs Inc. – Pipeline Products by Therapeutic Class
Paladin Labs Inc. – Pipeline Products By Target
Paladin Labs Inc. – Pipeline Products by Route of Administration
Paladin Labs Inc. – Pipeline Products By Mechanism of Action
Paladin Labs Inc. – Recent Pipeline Updates
Paladin Labs Inc. - Dormant Projects
QLT Inc. – Company Statement
QLT Inc. – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Financial Deals Landscape
NewLink Genetics Corporation, Deals Summary
NewLink Genetics Corporation, Pharmaceuticals & Healthcare, Deal Details
Venture Financing
BioProtection Systems Raises $0.12 Million In Venture Financing
NewLink Genetics Secures $30 Million In Series C Financing
NewLink Genetics Raises $7.5 Million In Series D Round Of Financing
NewLink Genetics Raises $17 Million In Series C Financing
Licensing Agreements
LIMR Enters Into Worldwide Licensing Agreement With NewLink Genetics
Equity Offering
NewLink Genetics Completes IPO Of Common Stock For $43.4 Million
NewLink Genetics Completes Private Placement Of $0.25 Million
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
NewLink Genetics Corporation, Key Information
NewLink Genetics Corporation, Key Facts
Paladin Labs Inc. – Pipeline by Indication, 2012
NewLink Genetics Corporation – Pipeline by Stage of Development, 2012
NewLink Genetics Corporation – Monotherapy Products in Pipeline, 2012
NewLink Genetics Corporation – Combination Treatment Modalities in Pipeline, 2012
Paladin Labs Inc. – Phase III, 2012
Paladin Labs Inc. – Phase II, 2012
Paladin Labs Inc. – Phase I, 2012
NewLink Genetics Corporation – Pipeline By Therapeutic Class, 2012
NewLink Genetics Corporation - Pipeline By Target, 2012
NewLink Genetics Corporation – Pipeline By Route of Administration, 2012
NewLink Genetics Corporation – Pipeline Products By Mechanism of Action, 2012
Paladin Labs Inc. – Recent Pipeline Updates, 2012
Paladin Labs Inc. - Dormant Developmental Projects,2012
NewLink Genetics Corporation, Subsidiaries
NewLink Genetics Corporation, Deals Summary
BioProtection Systems Raises $0.12 Million In Venture Financing
NewLink Genetics Secures $30 Million In Series C Financing
NewLink Genetics Raises $7.5 Million In Series D Round Of Financing
NewLink Genetics Raises $17 Million In Series C Financing
LIMR Enters Into Worldwide Licensing Agreement With NewLink Genetics
NewLink Genetics Completes IPO Of Common Stock For $43.4 Million
NewLink Genetics Completes Private Placement Of $0.25 Million

List of Figures
NewLink Genetics Corporation – Pipeline by Indication, 2012
NewLink Genetics Corporation – Pipeline by Stage of Development, 2012
NewLink Genetics Corporation – Monotherapy Products in Pipeline, 2012
NewLink Genetics Corporation – Combination Treatment Modalities in Pipeline, 2012
NewLink Genetics Corporation – Pipeline By Therapeutic Class, 2012
NewLink Genetics Corporation - Pipeline By Target, 2012
NewLink Genetics Corporation – Pipeline By Route of Administration, 2012
NewLink Genetics Corporation - Pipeline Products By Mechanism of Action, 2012

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• EarthLink: Strategic Corporate Assessment - Strategy, SWOT Analysis and 5-year Financial Insights with In-depth Company Profile
• ModusLink Global Solutions Inc,(MLNK) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• Net Savings Link, Inc.,(NSAV) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• CenturyLink Inc,(CTL) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• EarthLink Inc,(ELNK) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• Scientific Games Corporation - Company Analysis
• Issuer Direct Corporation,(ISDR) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• Local Corporation,(LOCM) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages
• Onstream Media Corporation,(ONSM) Profile and Financials, plus E-Commerce & Internet Industry Trends Analysis, Operating Ratio and Financial Averages